Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian D Green

Showing results (61-70 of 116) with videos related to

Pageof 12
Sort By:
Metabolites|October 31, 2018
Evidence That Parietal Lobe Fatty Acids May Be More Profoundly Affected in Moderate Alzheimer's Disease (AD) Pathology Than in Severe AD PathologyMuhammad L Nasaruddin, Xiaobei Pan, Bernadette McGuinness, et al.
Peptides|September 27, 2005
Effects on glucose homeostasis and insulin secretion of long term activation of the glucose-dependent insulinotropic polypeptide (GIP) receptor by N-AcGIP(LysPAL37) in normal miceNigel Irwin, Brian D Green, Victor A Gault, et al.
Analytical and Bioanalytical Chemistry|August 19, 2024
Development, validation and application of an LC-MS/MS method quantifying free forms of the micronutrients queuine and queuosine in human plasma using a surrogate matrix approachXiaobei Pan, Swathine Chandrasekaran, Jayne V Woodside, et al.
Biological Chemistry|January 31, 2007
Metabolic effects of sub-chronic ablation of the incretin receptors by daily administration of (Pro3)GIP and exendin(9-39)amide in obese diabetic (ob/ob) miceJeremy C Parker, Nigel Irwin, Kerry S Lavery, et al.
BMC Complementary Medicine and Therapies|January 28, 2022
Extracts of Sida cordifolia contain polysaccharides possessing immunomodulatory activity and rosmarinic acid compounds with antibacterial activityHaroon Iqbal, Claire L Wright, Sue Jones, et al.
Biological Chemistry|January 31, 2007
Characterisation and glucoregulatory actions of a novel acylated form of the (Pro3)GIP receptor antagonist in type 2 diabetesVictor A Gault, Kerry Hunter, Nigel Irwin, et al.
European Journal of Pharmacology|June 19, 2007
Effects of antidiabetic drugs on dipeptidyl peptidase IV activity: nateglinide is an inhibitor of DPP IV and augments the antidiabetic activity of glucagon-like peptide-1Nicola A Duffy, Brian D Green, Nigel Irwin, et al.
Archives of Biochemistry and Biophysics|April 13, 2007
Characterisation and biological activity of Glu3 amino acid substituted GIP receptor antagonistsVictor A Gault, Kerry Hunter, Nigel Irwin, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 22, 2019
A Human Relevant Defined Mixture of Persistent Organic Pollutants (POPs) Affects In Vitro Secretion of Glucagon-Like Peptide 1 (GLP-1), but Does Not Affect Translocation of Its ReceptorMaeve Shannon, Yuling Xie, Steven Verhaegen, et al.
Biochemical Pharmacology|July 25, 2006
Evaluation of the antidiabetic activity of DPP IV resistant N-terminally modified versus mid-chain acylated analogues of glucose-dependent insulinotropic polypeptideNigel Irwin, Gillian C Clarke, Brian D Green, et al.
Pageof 12

Showing results (61-70 of 116) with videos related to

Sort By:
Pageof 12
Metabolites|October 31, 2018
Evidence That Parietal Lobe Fatty Acids May Be More Profoundly Affected in Moderate Alzheimer's Disease (AD) Pathology Than in Severe AD PathologyMuhammad L Nasaruddin, Xiaobei Pan, Bernadette McGuinness, et al.
Peptides|September 27, 2005
Effects on glucose homeostasis and insulin secretion of long term activation of the glucose-dependent insulinotropic polypeptide (GIP) receptor by N-AcGIP(LysPAL37) in normal miceNigel Irwin, Brian D Green, Victor A Gault, et al.
Analytical and Bioanalytical Chemistry|August 19, 2024
Development, validation and application of an LC-MS/MS method quantifying free forms of the micronutrients queuine and queuosine in human plasma using a surrogate matrix approachXiaobei Pan, Swathine Chandrasekaran, Jayne V Woodside, et al.
Biological Chemistry|January 31, 2007
Metabolic effects of sub-chronic ablation of the incretin receptors by daily administration of (Pro3)GIP and exendin(9-39)amide in obese diabetic (ob/ob) miceJeremy C Parker, Nigel Irwin, Kerry S Lavery, et al.
BMC Complementary Medicine and Therapies|January 28, 2022
Extracts of Sida cordifolia contain polysaccharides possessing immunomodulatory activity and rosmarinic acid compounds with antibacterial activityHaroon Iqbal, Claire L Wright, Sue Jones, et al.
Biological Chemistry|January 31, 2007
Characterisation and glucoregulatory actions of a novel acylated form of the (Pro3)GIP receptor antagonist in type 2 diabetesVictor A Gault, Kerry Hunter, Nigel Irwin, et al.
European Journal of Pharmacology|June 19, 2007
Effects of antidiabetic drugs on dipeptidyl peptidase IV activity: nateglinide is an inhibitor of DPP IV and augments the antidiabetic activity of glucagon-like peptide-1Nicola A Duffy, Brian D Green, Nigel Irwin, et al.
Archives of Biochemistry and Biophysics|April 13, 2007
Characterisation and biological activity of Glu3 amino acid substituted GIP receptor antagonistsVictor A Gault, Kerry Hunter, Nigel Irwin, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 22, 2019
A Human Relevant Defined Mixture of Persistent Organic Pollutants (POPs) Affects In Vitro Secretion of Glucagon-Like Peptide 1 (GLP-1), but Does Not Affect Translocation of Its ReceptorMaeve Shannon, Yuling Xie, Steven Verhaegen, et al.
Biochemical Pharmacology|July 25, 2006
Evaluation of the antidiabetic activity of DPP IV resistant N-terminally modified versus mid-chain acylated analogues of glucose-dependent insulinotropic polypeptideNigel Irwin, Gillian C Clarke, Brian D Green, et al.
Pageof 12